Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug 24:16:17562864231190549.
doi: 10.1177/17562864231190549. eCollection 2023.

Impact of the updated chronic inflammatory demyelinating polyneuropathy guideline on everyday clinical practice

Suraj Muley  1 , Said R Beydoun  2
Affiliations
Editorial

Impact of the updated chronic inflammatory demyelinating polyneuropathy guideline on everyday clinical practice

Suraj Muley et al. Ther Adv Neurol Disord. .
No abstract available

Keywords: CIDP; diagnosis; guidelines; treatment.

PubMed Disclaimer

Conflict of interest statement

Dr Beydoun received research grants from AB Science, Alexion, Amylyx, Argenx, Genentech, Healey ALS Center—Massachusetts General Hospital, Janssen, Regeneron, Sanofi, and UCB Pharma; honoraria for consulting or speaking from Alexion, Alnylam, Argenx, CSL Behring, Grifols, Pfizer, and Takeda. Dr Muley received consulting fees from Takeda, Alexion, UCB, Horizon, and Argenx; honoraria for consulting or speaking for CSL Behring, Takeda, Argenx, Alexion, and Catalyst; royalties or licenses for UpToDate® articles (“Chronic inflammatory demyelinating polyneuropathy: etiology, clinical features, and diagnosis,” “Chronic inflammatory demyelinating polyneuropathy: treatment and prognosis,” and “Guillain–Barré syndrome in adults: treatment and prognosis”).

References

    1. Van den Bergh PYK, van Doorn PA, Hadden RDM, et al.. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force-second revision. J Peripher Nerv Syst 2021; 26: 242–268. - PubMed
    1. Van den Bergh PY, Hadden RD, Bouche P, et al.. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. Eur J Neurol 2010; 17: 356–363. - PubMed
    1. Rajabally YA, Nicolas G, Piéret F, et al.. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry 2009; 80: 1364–1368. - PubMed
    1. Allen JA, Lewis RA. CIDP diagnostic pitfalls and perception of treatment benefit. Neurology 2015; 85: 498–504. - PubMed
    1. Broers MC, van Doorn PA, Kuitwaard K, et al.. Diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in clinical practice: a survey among Dutch neurologists. J Peripher Nerv Syst 2020; 25: 247–255. - PMC - PubMed

Publication types

LinkOut - more resources